©2022 Stanford Medicine
Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control
Not Recruiting
Trial ID: NCT05208892
Purpose
The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective
regional technique for pain management following cleft palate procedures. However, it has not
been studied for patients undergoing tonsillectomy and adenoidectomy (T&A) procedures. The
goal of this study is to determine whether the SZMN block can be utilized to improve pain
control and decrease morbidity in pediatric patients undergoing T&A. An additional goal will
be to determine whether the use of dexmedetomidine as a local anesthetic adjunct can prolong
the analgesic effects of the SZMN block to cover the entire duration of pain experienced.
Official Title
Dexmedetomidine Use in Suprazygomatic Maxillary Nerve Blocks for Pediatric Adenotonsillectomy Pain Control
Stanford Investigator(s)
Stephanie Jiaying Pan
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Eligibility
Inclusion Criteria:
- Ages 6 months - 18 years
- Give consent/parental consent to participate in study
- Patients undergoing tonsillectomy and adenoidectomy
Exclusion Criteria:
- Participants who do not consent or have parental consent
- Patients who require urgent/emergent intervention
- Patients who undergo additional combined surgical procedures with separate incisions
(in addition to the adenotonsillectomy)
- Patients with known difficult airway, clinical hemodynamic instability, coagulopathy,
chronic pain history, chronic pain medication use, and unrepaired congenital heart
disease
- Patients under age 6 months
Intervention(s):
procedure: SZMN block
procedure: SZMN block with Dexmedetomidine
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Ban CH Tsui, MD
(650) 200-9107